WCN24-1970 CD11b deficiency ameliorates AKI-to-CKD progress via promoting alternative activation of macrophages

WCN24-1970 CD11b deficiency ameliorates AKI-to-CKD progress via promoting alternative activation of macrophages

Saved in:

Bibliographic Details
Main Authors:	Yiqin Shi, Huili Zhou, Xiaoqiang Ding
Format:	Article
Language:	English
Published:	Elsevier 2024-04-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024924001529
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

WCN24-1016 MINCLE RECEPTOR IN MACROPHAGE AND NEUTROPHIL CONTRIBUTES TO THE UNRESOLVED INFLAMMATION DURING THE TRANSITION FROM AKI TO CKD
by: Cui Wang, et al.
Published: (2024-04-01)

Crosstalk between macrophages and adjacent cells in AKI to CKD transition
by: Yanping Lin, et al.
Published: (2025-12-01)

Depletion of macrophages with clodronate liposomes partially attenuates renal fibrosis on AKI–CKD transition
by: Zhizhi Hu, et al.
Published: (2023-12-01)

WCN25-3504 KIM-1-dependent downregulation of DNase-I drives AKI-to-CKD transition
by: Lakshman Gunaratnam, et al.
Published: (2025-02-01)

WCN24-931 AKI PHENOTYPES IN UGANDAN CHILDREN HOSPITALIZED WITH HYPOXEMIA AND MALARIA
by: Andrea Conroy, et al.
Published: (2024-04-01)

WCN24-1533 ONE-YEAR OUTPATIENT FOLLOW-UP OF AKI SURVIVORS
by: Rodrigo Ramalho, et al.
Published: (2024-04-01)

WCN24-2473 FACTORS ASSOCIATED WITH MORTALITY IN PATIENTS WITH AKI AND COVID-19 INFECTION
by: Dr Mahendra Atlani, et al.
Published: (2024-04-01)

WCN25-403 THIRTY DAYS OUTCOMES OF SUSTAINED LOW EFFICIENCY DIALYSIS IN CRITICALLY ILL PATIENTS OF AKI AND ACUTE ON CKD
by: MD.MAHBOOB ALAM, et al.
Published: (2025-02-01)

WCN24-2242 CORRELATION OF LEVELS OF INFLAMMATORY MARKERS OF COVID19 WITH AKI SEVERITY AND OUTCOME
by: Amol Kulkarni, et al.
Published: (2024-04-01)

WCN24-234 ADVANCED BIOMARKERS TO PREDICT MORTALITY AND THE OCCURRENCE OF AKI IN PATIENTS WITH COVID-19
by: Rumen Filev, et al.
Published: (2024-04-01)

Myeloid EGFR deficiency accelerates recovery from AKI via macrophage efferocytosis and neutrophil apoptosis
by: Yu Pan, et al.
Published: (2025-05-01)

The critical role of ion channels in kidney disease: perspective from AKI and CKD
by: Chen sui zi Li, et al.
Published: (2025-12-01)

WCN24-1129 CKD-MBD Status in Maintenance Hemodialysis Patients in Bangladesh
by: Farnaz Nobi, et al.
Published: (2024-04-01)

WCN24-2168 PHENOTYPE OF CKD-BMD IN A DIALYSIS POPULATION OF MEXICO
by: Lia Daniela Luna-Navarro, et al.
Published: (2024-04-01)

WCN24-2234 SGLT2i DURING AKI AND ITS ASSOCIATION WITH MAYOR ADVERSE KIDNEY EVENTS
by: Luz Alcantar Vallin, et al.
Published: (2024-04-01)

WCN24-244 The utility of Indoxyl sulfate as a biomarker for early detection of CKD
by: Mizuki Hisano, et al.
Published: (2024-04-01)

WCN24-2070 Calprotectin Is Associated with Vascular Calcification and Cardiovascular Complications During CKD
by: Serban Ardeleanu, et al.
Published: (2024-04-01)

Protein lactylation of citrate synthase promotes the AKI-CKD transition by activating the NLRP3 inflammasome
by: Fang Yu, et al.
Published: (2025-08-01)

Research progress on the role of G2/M cell cycle arrest in the AKI-CKD transition
by: LIU Shui-ying, et al.
Published: (2020-01-01)

WCN24-1244 BUTYRATE IMPROVES THE METABOLISM OF PROXIMAL TUBULAR CELLS AND ATTENUATES RENAL INJURY IN OXALATE-INDUCED AKI
by: Orestes Foresto-Neto, et al.
Published: (2024-04-01)

WCN24-1211 To determine the effectiveness of Lactoferrin in improving Anemia in iron replete CKD patients
by: Kushal Kekan, et al.
Published: (2024-04-01)

WCN24-1258 HIGH PREVALENCE OF OSTEOPOROSIS IN ELDERLY PATIENTS WITH ADVANCED CKD: CALL FOR ACTION!
by: Sayuri Kuhnen Hayashi, et al.
Published: (2024-04-01)

FUT8 upregulates CD36 and its core fucosylation to accelerate pericyte-myofibroblast transition through the mitochondrial-dependent apoptosis pathway during AKI-CKD
by: Yaxi Shang, et al.
Published: (2024-11-01)

Integrated multiomics analysis identifies potential biomarkers and therapeutic targets for autophagy associated AKI to CKD transition
by: Yaojun Wang, et al.
Published: (2025-04-01)

WCN24-900 ASSOCIATION OF URINARY SEDIMENTS SCORE WITH THE SEVERITY AND DIFFERENT TYPE OF ACUTE KIDNEY INJURY (AKI) IN HOSPITALIZED PATIENTS
by: MD AJFAR SAZID KHAN
Published: (2024-04-01)

WCN24-1764 EPIDEMIC OF CHEMICAL-INDUCED MULTIPLE ORGAN FAILURE PRESENTING AS AKI IN YOUNG CHILDREN IN THE GAMBIA – THE CLINICIANS' PERSPECTIVE
by: Uzoamaka Muoneke, et al.
Published: (2024-04-01)

WCN24-2154 ANTIOXIDANT AND MITOCHONDRIAL EFFECTS OF OSTHOLE IN A MODEL OF CONTRAST INDUCED-ACUTE KIDNEY INJURY (CI-AKI)
by: Fernando Enrique García Arroyo, et al.
Published: (2024-04-01)

Proteasomal activation ameliorates neuronal phenotypes linked to FBXO11-deficiency
by: Anne Gregor, et al.
Published: (2025-04-01)

WCN24-1900 BLOOD UREA NITROGEN AND URINARY OUTPUT AT 24 HOURS OF TREATMENT DURING CRRT PERFORMANCE AS PREDICTORS FOR RENAL RECOVERY IN AKI KDIGO 3
by: Lilia María Rizo Topete, et al.
Published: (2024-04-01)

WCN24-398 REPORT ON STOP-ACEi TRIAL: REVIEWING CYSTATIN C LEVELS IN CKD PATIENTS
by: Sebastian Spencer, et al.
Published: (2024-04-01)

WCN24-1362 RISK FACTORS INVOLVED IN ERYTHROPOIETIN RESISTANCE IN PATIENTS WITH CKD IN A HEMODIALYSIS UNIT
by: Enrique Fleuvier Morales López, et al.
Published: (2024-04-01)

WCN24-2260 A RANDOMIZED CONTROLLED TRIAL OF ALLOPURINOL FOR CVD IN CKD: STUDY POPULATION CHARACTERISTICS
by: Vivek Kumar, et al.
Published: (2024-04-01)

WCN24-2178 Risk factors of CKD incidence in Korea NHIS data : Focusing on the influence of diabetes
by: Ki Ryang Na, et al.
Published: (2024-04-01)

WCN24-971 CORRELATION BETWEEN CAROTID, CORONARY AND PERIPHERAL ATHEROSCLEROSIS IN NON-DIALYTIC CKD PATIENTS
by: Erika Carneiro, et al.
Published: (2024-04-01)

WCN24-2145 ACUTE EFFECT OF FERRIC CARBOXYMALTOSE ON OXIDATIVE STRESS IN NON-DIALYSIS CKD PATIENTS
by: Ana Maria Mehedinti, et al.
Published: (2024-04-01)

WCN25-3776 CAN WE IMPROVE ACCURACY OF DIAGNOSING IRON DEFICIENCY AMONG CKD PATIENTS?
by: Nageshwar Panchal, et al.
Published: (2025-02-01)

WCN25-1136 FRAILTY IN CKD
by: Beatriz Mendes, et al.
Published: (2025-02-01)

WCN25-4212 THE IMPACT OF RHABDOMYOLYSIS INDUCED AKI ON PATIENT OUTCOMES
by: k sai sindhu singh, et al.
Published: (2025-02-01)

WCN24-746 SUPPLEMENTATION WITH SULFORAPHANE INCREASES NRF2 mRNA EXPRESSION IN NONDIALYSIS CKD PATIENTS
by: Denise Mafra, et al.
Published: (2024-04-01)

WCN24-2175 Priorities in nutrition of health professionals and population with CKD without dialysis, Chilean preliminary data
by: Francisca Peña, et al.
Published: (2024-04-01)